There was no difference between HD and MS in the proportion within CD4+ cells of CD4+CD25+CD127lo (7.20 ± 0.546% vs. 7.48 ± 0.502%, p = 0.815) or of CD4+CD25+CD127loFoxp3+ (6.19 ± 0.516 vs. 6.62 ± 0.516%, p = 0.573, Fig. 1Be). The gene discussed is CD4; the disease is myeloid sarcoma.